Sadik Kassim
- Role
- Chief Technology Officer (Genomic Medicines) at Danaher
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Sadik Kassim
Experienced Scientist/Executive with a successful track record in the biotechnology…
Experience
Chief Technology Officer (Genomic Medicines)
Dec 2021 — Present
Responsible for the development of platform R&D strategies for Genomic Medicines. • Responsible for identifying and driving the optimal path for implementation of Genomic Medicines R&D strategies across Danaher Operating Companies. •Lead scientific and technical diligence efforts related to external R&D collaborations, venture investments, and M&A opportunities for Genomic Medicines.
Education
Tulane University
Bachelor of Science (BS), Cell/Cellular and Molecular Biology
1998 — 2002
Louisiana State University
Doctor of Philosophy (PhD), Microbiology and Immunology
2002 — 2007
Skills
- Gene Therapy
- Aav Vectors
- Cell Culture
- Oncology
- T Cells
- Cancer
- Gmp
- Immunology
- Phase Ii Clinical Trials
- Adeno Associated Virus Vectors
- Cancer Immunotherapy
- Rare Diseases
- Lifesciences
- Cell Therapy
- Pharmaceutical Process Development
- Molecular Biology
- Proteomics
- Research
- Phase I Clinical Trials
- Clinical Research
- Familial Hypercholesterolemia
- Clinical Development
- Car T Cell Therapy
- Science
- Cell Biology
- Big Data Analytics
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.